Clients

Neovasc Inc.

Company Snapshot: Neovasc Inc.

NVCN
Last Change Volume High Low

Company Overview

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Client News

  1. May 23 2022 Neovasc to Participate in H.C. Wainwright Global Investment Conference
  2. May 16 2022 Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
  3. May 16 2022 Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
  4. May 16 2022 Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule